Showing results (151-160 of 197) with videos related to
Sort By:
Pageof 20
Developmental Cell|August 28, 2025
Long-range deployment of tumor-antigen-specific cytotoxic T lymphocytes inhibits lung metastasis of breast cancerYue Xing, Yan Zhou, Ruxin Wang, et al.Nature Communications|April 25, 2018
Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1Yinghua Zhu, Yujie Liu, Chao Zhang, et al.Cell|February 4, 2018
CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer StemnessShicheng Su, Jianing Chen, Herui Yao, et al.Cancer Cell|April 13, 2011
CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3Jingqi Chen, Yandan Yao, Chang Gong, et al.Molecular Cancer|January 4, 2022
circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancerYun Ling, Gehao Liang, Qun Lin, et al.Nature Communications|March 31, 2018
Publisher Correction: Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLCJunchao Cai, Lishan Fang, Yongbo Huang, et al.International Journal of Cancer|May 16, 2018
LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancerWei Wu, Fei Chen, Xiuying Cui, et al.Nature Communications|June 20, 2017
Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLCJunchao Cai, Lishan Fang, Yongbo Huang, et al.Nature Communications|April 26, 2018
A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patientsHuiping Li, Jiang Liu, Jianing Chen, et al.Nature Cancer|May 29, 2025
Cardiomyocyte-localized CCDC25 senses NET DNA to promote doxorubicin cardiotoxicity by activating autophagic fluxMan Nie, Dexin Lei, Zhou Liu, et al.Pageof 20